Barely Significant

Excerpts

514,629 sentences

highly significantp < 0.00010.0× alphaqualifiedgold
Furthermore, the 1745 cm −1 band (C Created by potrace 1.16, written by Peter Selinger 2001-2019 ]]> O stretching of esters/lipids) exhibited highly significant differences ( p < 0.0001) between treated and untreated bacteria, particularly for 1a and 1b, suggesting perturbations in the lipid components of the cell envelope or extracellular matrix.
highly significantP < 0.00010.0× alphaqualifiedgold
Analyses of the comparison of fed sand fly counts for each treatment group resulted in a highly significant reduction ( P < 0.0001) at all post-infestation time points for those dogs treated with Advantix®.
highly significantp < 0.00010.0× alphaqualifiedgold
The apparent 10.2/7.6 mmHg difference between inpatients and outpatients was only slightly reduced to 8.0/5.1 mmHg after adjustment for baseline and remained highly significant (p < 0.0001/p < 0.0001) even after correction for cluster effects.
highly significantP < 0.00010.0× alphaqualifiedgold
Furthermore, the compound induced a highly significant (P < 0.0001) antiproliferative effect at 72 vs. 96h exposure period (concentration range 31.25–250 μM in MDA-MB-231 and 15.62–125 μM in MDA-MB-468 cell line) as indicated by the significant reduction in the IC 50 values, in particular for MDA-MB-468 cells.
nominally significantp < 0.00010.0× alphagold
Of note, each comparison of atropine sulfate 0.01% versus vehicle and atropine sulfate 0.03% versus vehicle was nominally significant ( p < 0.0001 and p = 0.0023, respectively) (Fig. 3 ). s In Fast Progressor Subgroup 2 (progression − 0.75 D/year or worse at baseline, n = 225), the mean (least squares means) APR from baseline to month 24 was − 0.53 D (95% CI − 0.63, − 0.43) in the vehicle group and − 0.38 D (95% CI − 0.47, − 0.30) in the combined atropine sulfate group.
a decreasing trendP < 0.00010.0× alphagold
Prevalence and trend of TTIs in blood donors according to donor status The analysis of first-time donors (who comprised 23.3% of all donors) showed a decreasing trend in the prevalence of HBV ( P < 0.0001, R: -0.98), HIV ( P < 0.18, R: -0.49), HCV ( P < 0.0001, R: − 0.98) and HTLV 1/2 ( P < 0.0001, R: − 0.95) from 2010 to 2018.